VISTA-Ig

N/A

Report date: 2025/03/20 09:15:59

Base Information

Drug NameVISTA-Ig
Drug Alias NameV-domain Immunoglobulin Suppressor of T cell Activation immunoglobulinVISTA pathway agonists
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionV-domain Ig suppressor of T-cell activation stimulants
TargetsV-domain Ig suppressor of T-cell activation
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmuRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesRoche Holding LtdImmunext Inc
Inactive CompaniesImmuRx Inc
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A